Cover Image

Letter to the Editor: indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus

Saved in:

Bibliographic Details
Main Authors:	Nick Ballew (Author), Aneela Mian (Author), Roger Abramino Levy (Author), Matt Bradley (Author)
Format:	Book
Published:	Becaris Publishing Limited, 2022-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Letter in reply: indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus
by: Ian N Bruce, et al.
Published: (2022)

Belimumab in systemic lupus erythematosus
by: Ankita Srivastava
Published: (2016)

Anifrolumab for the treatment of refractory chilblain lupus erythematosus
by: Michael J. Woodbury, BS, et al.
Published: (2024)

Belimumab for systemic lupus erythematosus - Focus on lupus nephritis
by: Marlene Plüß, et al.
Published: (2022)

Management of Pediatric Systemic Lupus Erythematosus: Focus on Belimumab
by: Guzman M, et al.
Published: (2020)

Pharmacoeconomic analysis of using belimumab for the treatment of systemic lupus erythematosus
by: A. G. Tolkushin, et al.
Published: (2018)

Cost-effectiveness analysis of Belimumab in patients with systemic lupus erythematosus in Spain
by: Silvia Díaz-Cerezo, et al.
Published: (2015)

Spotlight on anifrolumab and its potential for the treatment of moderate-to-severe systemic lupus erythematosus: evidence to date
by: Felten R, et al.
Published: (2019)

Budget Impact Analysis Of Subcutaneous Belimumab In Patients With Systemic Lupus Erythematosus In Spain
by: Cevey M, et al.
Published: (2019)

Alopecia secondary to severe discoid lupus responding to anifrolumab
by: Shannon Han, BS, et al.
Published: (2023)

Letter in reply: Crusted scabies mimicking a lupus flare after rituximab and belimumab
by: Grigoriy Androsov, BS, et al.
Published: (2021)

Cancer in systemic lupus erythematosus; a letter to the editor on current concepts
by: Leila Alem, et al.
Published: (2023)

Evaluation of intra‐ and inter‐individual variations in plasma belimumab concentrations in adult patients with systemic lupus erythematosus
by: Chisato Yoshijima, et al.
Published: (2024)

Belimumab in a Patient with Systemic Lupus Erythematosus with Juvenile Onset and Steroid-induced Diabetes: Clinical Case
by: Maria I. Kaleda, et al.
Published: (2023)

The rapid inhibition of B-cell activation markers by belimumab was associated with disease control in systemic lupus erythematosus patients
by: Jing Wang, et al.
Published: (2023)

Novel treatment of systemic lupus erythematosus: belimumab is now available for Russian patients over 5 years old
by: article editorial
Published: (2020)

FDA approves belimumab for treatment of children with lupus nephritis
by: article Editorial
Published: (2022)

Population model‐based analysis of the memory B‐cell response following belimumab therapy in the treatment of systemic lupus erythematosus
by: Richard Dimelow, et al.
Published: (2023)

Rapid response of refractory subacute cutaneous lupus after single dose anifrolumab
by: Rebecca G. Gaffney, MD, et al.
Published: (2024)

Usefulness of Belimumab in Adult Patients With Systemic Lupus Erythematosus Evaluated Using Single Indexes: A Meta-Analysis and Systematic Review
by: Chisato Yoshijima, BSPharm, et al.
Published: (2024)

Association Between Changes in BLyS Levels and the Composition of B and T Cell Compartments in Patients With Refractory Systemic Lupus Erythematosus Treated With Belimumab
by: Francesca Regola, et al.
Published: (2019)

New treatment options for lupus – a focus on belimumab
by: Chiche L, et al.
Published: (2012)

Successful treatment of severe chronic cutaneous lupus with anifrolumab: A series of 6 cases
by: Eric H. Kowalski, MD, et al.
Published: (2023)

Refractory dermatomyositis responsive to anifrolumab
by: Phillip S. Ang, BA, et al.
Published: (2024)

Subacute cutaneous lupus erythematosus versus discoid lupus erythematosus: A challenging diagnosis
by: Julianne Kleitsch, BA, et al.
Published: (2023)

Serum IFN-γ Predicts the Therapeutic Effect of Belimumab in Refractory Lupus Nephritis Patients
by: Liu S, et al.
Published: (2024)

Efficacy and safety of belimumab in lupus nephritis patients: a real-world observational study in China
by: Meng Tan, et al.
Published: (2023)

Letter to the Editor Regarding 'Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab Versus Dupilumab in Moderate-to-Severe Atopic Dermatitis'
by: Mike Bastian, et al.
Published: (2024)

A case of Rowell syndrome with excellent improvement following anifrolumab
by: Chelsea Shope, BA, et al.
Published: (2023)

Letter to the editor: network meta-analysis for indirect comparison of lanadelumab and berotralstat for the treatment of hereditary angioedema
by: Max Schlueter, et al.
Published: (2024)

Chronic cutaneous lupus erythematosus with systemic symptoms or systemic lupus erythematosus?
by: Suresh K. Malhotra, et al.
Published: (2016)

An impressive case of Rowell syndrome with extensive mucosal involvement successfully treated with anifrolumab
by: Daniel R. Antohi, BA, et al.
Published: (2024)

Systemic Lupus Erythematosus
Published: (2012)

Discoid lupus erythematosus
by: Anilkumar L Bhoweer, et al.
Published: (2018)

Systemic lupus erythematosus
by: Jayakumar N, et al.
Published: (2006)

Congenital lupus erythematosus
by: Taseer Ahmed Bhatt, et al.
Published: (2011)

Lupus erythematosus paniculitis
by: Alizade Narges, et al.
Published: (2017)

Moulage: "Lupus Erythematosus"
by: Beatrix Patzak
Published: (2011)

EXANTHEMATOUS LUPUS ERYTHEMATOSUS
by: N.S. Podchernyaeva, et al.
Published: (2006)

EXANTHEMATOUS LUPUS ERYTHEMATOSUS
by: N.S. Podchernyaeva, et al.
Published: (2006)